COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

Search

Hims & Hers Health Inc

Ouvert

SecteurConsommation de base

16.79 -3.12

Résumé

Variation du prix de l'action

24h

Actuel

Min

16.37

Max

17.61

Chiffres clés

By Trading Economics

Revenu

-27M

16M

Ventes

54M

599M

P/E

Moyenne du Secteur

36.472

33.023

Marge bénéficiaire

2.633

Employés

1,637

EBITDA

-7.3M

30M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+70.46% upside

Dividendes

By Dow Jones

Prochains Résultats

23 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-5.6B

4.4B

Ouverture précédente

19.91

Clôture précédente

16.79

Sentiment de l'Actualité

By Acuity

100%

0%

124 / 133 Classement par Consumer defensive

Score Technique

By Trading Central

Confiance

Bullish Evidence

Hims & Hers Health Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

9 févr. 2026, 09:37 UTC

Principaux Mouvements du Marché

Novo Nordisk Shares Jump After Hims & Hers Scraps Plan For Copycat Weight-Loss Pill

5 août 2025, 00:05 UTC

Actions en Tendance

Stocks to Watch: Palantir Technologies, Hims & Hers Health, Vertex Pharmaceuticals, Kyndryl

29 avr. 2025, 12:54 UTC

Principaux Mouvements du Marché

Hims & Hers Rallies After Novo Nordisk Deal on Wegovy

4 avr. 2025, 22:38 UTC

Actions en Tendance

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

1 avr. 2025, 23:15 UTC

Principaux Mouvements du Marché

Hims & Hers Adds Eli Lilly's Zepbound in Expansion of Weight-Loss Offerings -- 2nd Update

25 févr. 2025, 15:33 UTC

Principaux Mouvements du Marché

Novo Nordisk Shares Rise as Hims & Hers to Stop Mimicking Weight-Loss Drugs

9 févr. 2026, 17:41 UTC

Résultats
Acquisitions, Fusions, Rachats

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, AppLovin, Monday.com, Valaris, and More -- Barrons.com

9 févr. 2026, 17:31 UTC

Résultats
Acquisitions, Fusions, Rachats

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Monday.com, Valaris, Cleveland-Cliffs, and More -- Barrons.com

9 févr. 2026, 15:15 UTC

Résultats

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Valaris, Monday.com, Cleveland-Cliffs, and More -- Barrons.com

9 févr. 2026, 15:07 UTC

Actions en Tendance

Stocks to Watch Monday: Novo Nordisk, Hims & Hers, Apollo -- WSJ

9 févr. 2026, 13:13 UTC

Résultats

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Kroger, Nvidia, Monday.com, and More -- Barrons.com

2 nov. 2025, 10:30 UTC

Acquisitions, Fusions, Rachats

Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk -- Heard on the Street -- WSJ

22 oct. 2025, 21:25 UTC

Résultats

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

5 août 2025, 20:44 UTC

Résultats

These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 août 2025, 18:17 UTC

Résultats

These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 août 2025, 17:26 UTC

Résultats
Acquisitions, Fusions, Rachats

Hims & Hers Had a Tough Quarter. Weight-Loss Drugs Are Only One Problem. -- Barrons.com

5 août 2025, 15:25 UTC

Résultats

Correction to These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Caterpillar, BP, and More -- Barrons.com

5 août 2025, 11:27 UTC

Résultats

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 août 2025, 10:55 UTC

Résultats

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 août 2025, 10:36 UTC

Résultats

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

29 juil. 2025, 16:55 UTC

Résultats

The Obesity Bubble Has Finally Burst. Novo Nordisk Shares Drop 21%. -- Barrons.com

24 juin 2025, 10:26 UTC

Market Talk

Novo Nordisk Sends Clear Message on Copycat Drugs -- Market Talk

3 juin 2025, 15:03 UTC

Acquisitions, Fusions, Rachats

Hims & Hers Seeks Growth in Europe as Weight-Loss Business Shifts -- Barrons.com

7 mai 2025, 13:56 UTC

Résultats

Novo Nordisk Stock Jumps After Earnings. Compounding Market's Growth Took it By Surprise -- Barrons.com

6 mai 2025, 14:24 UTC

Résultats

Hims & Hers Stock Is Higher After Earnings. The Sales Outlook Looks Low. -- Barrons.com

30 avr. 2025, 09:30 UTC

Actualités

Why New Wegovy Deals Won't Restore Novo's Obesity Lead -- Heard on the Street -- WSJ

2 avr. 2025, 16:53 UTC

Actualités

Hims & Hers Zepbound Offering Won't Bring Needed Sales Boom -- Analysis

19 mars 2025, 15:54 UTC

Actualités

Sale of Ozempic Knockoffs Are Supposed to End Soon. Telehealth Companies Aren't Happy. -- WSJ

21 févr. 2025, 23:20 UTC

Résultats

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More -- Barrons.com

Comparaison

Variation de prix

Hims & Hers Health Inc prévision

Objectif de Prix

By TipRanks

70.46% hausse

Prévisions sur 12 Mois

Moyen 32.95 USD  70.46%

Haut 60 USD

Bas 16.5 USD

Basé sur 12 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

12 ratings

3

Achat

6

Maintien

3

Vente

Score Technique

By Trading Central

36.685 / 52.35Support & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Bullish Evidence

Sentiment

By Acuity

124 / 133Classement par Consommation de base

Sentiment de l'Actualité

Très Fortes Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
help-icon Live chat